An apparent enhancement of caspase-10 cleavage in cisplatin/LA-12 and TRAIL-treated prostate cancer cells prompted us to investigate in more detail its possible involvement in the cooperative cytotoxic action of the drugs. The gene discussed is CASP10; the disease is Familial prostate cancer.